Prevalence and predictors of perceived stigmatization in adult patients with moderate-to-severe atopic dermatitis in France
J Eur Acad Dermatol Venereol
.
2023 Jan;37(1):e80-e81.
doi: 10.1111/jdv.18515.
Epub 2022 Aug 20.
Authors
Bruno Halioua
1
,
Marie Bastien
2
,
Charles Taieb
3
,
Claire Thenie
4
,
Charlotte Veniard
4
,
Margaux Noel
4
,
Laurent Misery
5
Affiliations
1
Department of Dermatology, Center of dermatology, Paris, France.
2
Department of Dermatology, Hôpital d'Instruction des Armées Begin, Saint Mandé, France.
3
Patients Priority Department, European Market Maintenance Assessment [EMMA], Fontenay Sous Bois, France.
4
Sanofi, Paris, France.
5
Department of Dermatology, Centre Hospitalier Universitaire de Brest, Brest, Brest, France.
PMID:
35972022
DOI:
10.1111/jdv.18515
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Adult
Dermatitis, Atopic* / epidemiology
France / epidemiology
Humans
Prevalence
Severity of Illness Index
Stereotyping
Grants and funding
Sanofi